These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 27021087

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The effect of liposomes on the growth and sensitivity of Mycobacterium smegmatis to isoniazide].
    Troshkina OA, Salina EG, Sorokoumova GM, Kaprel'iants AS, Selishcheva AA.
    Prikl Biokhim Mikrobiol; 2007; 43(1):47-52. PubMed ID: 17345858
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations.
    Kambli P, Ajbani K, Nikam C, Khillari A, Shetty A, Udwadia Z, Georghiou SB, Rodwell TC, Catanzaro A, Rodrigues C.
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1227-9. PubMed ID: 26459538
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
    Imperiale BR, Di Giulio ÁB, Adrián Cataldi A, Morcillo NS.
    J Antibiot (Tokyo); 2014 Nov; 67(11):749-54. PubMed ID: 24894185
    [Abstract] [Full Text] [Related]

  • 6. Action of fluoroquinolones and Linezolid on logarithmic- and stationary-phase culture of Mycobacterium tuberculosis.
    García-Tapia A, Rodríguez JC, Ruiz M, Royo G.
    Chemotherapy; 2004 Nov; 50(5):211-3. PubMed ID: 15523179
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
    Zhang T, Shen W, Liu M, Zhang R, Wang M, Li L, Wang B, Guo H, Lu Y.
    Eur J Med Chem; 2015 Nov 02; 104():73-85. PubMed ID: 26435513
    [Abstract] [Full Text] [Related]

  • 9. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003.
    Huang TS, Kunin CM, Shin-Jung Lee S, Chen YS, Tu HZ, Liu YC.
    J Antimicrob Chemother; 2005 Dec 02; 56(6):1058-62. PubMed ID: 16204341
    [Abstract] [Full Text] [Related]

  • 10. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y, Shiohira CM, Yamane N.
    Int J Antimicrob Agents; 2005 Oct 02; 26(4):292-7. PubMed ID: 16150578
    [Abstract] [Full Text] [Related]

  • 11. Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
    Suzuki Y, Nakajima C, Tamaru A, Kim H, Matsuba T, Saito H.
    Int J Antimicrob Agents; 2012 May 02; 39(5):435-9. PubMed ID: 22421328
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A, Schubert S.
    Int J Antimicrob Agents; 2010 Sep 02; 36(3):216-21. PubMed ID: 20630710
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T, Drlica K.
    J Antimicrob Chemother; 2003 Dec 02; 52(6):1025-8. PubMed ID: 14613961
    [Abstract] [Full Text] [Related]

  • 15. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey.
    Umubyeyi AN, Rigouts L, Shamputa IC, Fissette K, Elkrim Y, de Rijk PW, Struelens MJ, Portaels F.
    J Antimicrob Chemother; 2007 May 02; 59(5):1031-3. PubMed ID: 17329272
    [Abstract] [Full Text] [Related]

  • 16. In Vitro Study of the Modulatory Effects of Levofloxacin and BCG on Secretion of Proinflammatory Cytokines in Infiltrative Pulmonary Tuberculosis.
    Serebryakova VA, Urazova OI, Novitsky VV, Vengerovskii AI, Kononova TE.
    Bull Exp Biol Med; 2018 Dec 02; 166(2):225-228. PubMed ID: 30488211
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity against Mycobacterium tuberculosis of levofloxacin, moxifloxacin and UB-8902 in combination with clofazimine and pretomanid.
    López-Gavín A, Tudó G, Vergara A, Hurtado JC, Gonzalez-Martín J.
    Int J Antimicrob Agents; 2015 Nov 02; 46(5):582-5. PubMed ID: 26421981
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.